Prescription Drug Pricing Reform in the Inflation Reduction Act: What Pharmaceutical Companies Need to Know

Prescription Drug Pricing Reform in the Inflation Reduction Act: What Pharmaceutical Companies Need to Know Webcast

• Friday, September 16, 2022 12:00 PM - 1:00 PM

The recently enacted Inflation Reduction Act will lead to significant changes in how certain drug products are priced and paid for under Medicare. Join Covington’s experts as they discuss the following provisions and their implications for drug and biologics manufacturers at various stages of the product life cycle.

• Drug price negotiation
• Medicare Part B and Part D inflation-based rebates
• Medicare Part D changes

To register, click here.

Presenters:

Krista Carver, Partner
kcarver@cov.com

Rujul Desai, Of Counsel
rdesai@cov.com

Michael Stern, Of Counsel
mstern@cov.com

Kristie Gurley, Associate
kgurley@cov.com

Friday, September 16, 2022
12 - 1 p.m. ET
9 - 10 a.m. PT

Log-in details will be provided upon registration.

CLE credit will be offered.